Dual actions of A2A adenosine receptor antagonists on motor dysfunction and neurodegenerative processes
β Scribed by Ennio Ongini; Angela Monopoli; Francesco Impagnatiello; Silva Fredduzzi; Michael Schwarzschild; Jiang-Fan Chen
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 160 KB
- Volume
- 52
- Category
- Article
- ISSN
- 0272-4391
- DOI
- 10.1002/ddr.1137
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract A novel compound, __N__^6^β(4βhydroxybenzyl)adenosine, isolated from __Gastrodia elata__ and which has been shown to be a potential therapeutic agent for preventing and treating neurodegenerative disease, was found to target both the adenosine A~2A~ receptor (A~2A~R) and the equilibrati
There is increasing evidence that adenosine (ADO) and dopamine (DA) interact directly in the basal ganglia via actions at ADO A,, and DA D2 receptors, respectively. The purpose of this study was to determine 1) the extent to which these receptors modulate endogenous GABA release in discrete regions
There is evidence that adenosine may participate in the regulation of sleep and wakefulness in the mammalian central nervous system. To understand whether the adenosine receptor subtypes, A, and A > , . , , are involved in the modulation of sleep and waking, we carried out electroencephalographic (E